Clinical Trials Browser

Phase 3 × Prostatic Neoplasms × Prednisolone × Clear all

Prostatic Neoplasms

NCT06952803 2026-03-10

EvoPAR-PR02

Phase 3 Recruiting

700 enrolled

Genitourinary

Prostatic Neoplasms

NCT06764485 2026-01-28

rechARge

Phase 3 Recruiting

960 enrolled

Genitourinary

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT05288166 2025-06-27

CYCLONE 3

Phase 3 Active not recruiting

925 enrolled 12 charts

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms, Urogenital Neoplasms

NCT03072238 2025-06-06

IPATential150

Phase 3 Completed

1,101 enrolled 35 charts

Genitourinary

Prostatic Neoplasms

NCT03834519 2025-05-18

KEYLYNK-010

Phase 3 Completed

793 enrolled 23 charts

Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT02288247 2025-04-08

PRESIDE

Phase 3 Completed

688 enrolled 13 charts

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT02043678 2025-02-19

ERA 223

Phase 3 Completed

806 enrolled 32 charts

Genitourinary

Prostatic Neoplasms

NCT01308580 2017-04-17

PROSELICA

Phase 3 Completed

1,200 enrolled 25 charts

Genitourinary

Prostatic Neoplasms

NCT00519285 2016-07-22

VENICE

Phase 3 Completed

1,224 enrolled 21 charts

Genitourinary

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

NCT00638690 2014-04-30

Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Phase 3 Completed

1,195 enrolled 12 charts

Genitourinary

Prostatic Neoplasms

Clinical Trials

MK-2400-001

EvoPAR-PR02

rechARge

CYCLONE 3

IPATential150

KEYLYNK-010

PRESIDE

ERA 223

PROSELICA

VENICE

Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy